Summary. Viral antibodies were tested in a cohort of 44 isletcell antibody-positive individuals age 7-19 years, and 44 of their islet cell antibody-negative age and sex-matched classmates selected from a population study of 4208 pupils who had been screened for islet cell antibodies. Anti-coxsackie B1-5 IgM responses were detected in 14 of 44 (32 %) of the islet cell antibody-positive subjects and in 7 of 44 (16 % ) control subjects. This difference did not reach the level of statistical significance. None of the islet cell antibody-positive subjects had specific IgM antibodies to mumps, rubella, or cytomegalovirus. There was also no increase in the prevalence or the mean titres of anti-mumps-IgG or IgA and anti-cytomegalovirus-IgG in islet cell antibody-positive subjects compared to control subjects. These results do not suggest any association between islet cell antibodies, and possibly insulitis, with recent mumps, rubella or cytomegalovirus infection. Further studies are required to clarify the relationship between islet cell antibodies and coxsackie B virus infections.
There is considerable evidence implicating virus infection in the pathogenesis of Type 1 (insulin-dependent) diabetes mellitus, particularly infection with coxsackie B and other enteroviruses, but also mumps, rubella and cytomegalovirus. This evidence is based on studies in animal models [1] , anecdotal case reports in which viruses have been isolated from patients at the time of Type 1 diabetes onset [2] [3] [4] and seroepidemiological studies to determine the prevalence of virus-specific IgM responses in patients with recently diagnosed Type 1 diabetes [5] [6] [7] [8] [9] , indicating that virus infection is present in a proportion of patients around the time of diabetes onset. In view of the long incubation period before clinical diabetes becomes apparent in man, it is pertinent to consider whether virus infection may be involved in the initiation of the disease process, rather than simply the precipitation of disease in patients with already compromised Beta-cell function. To this end we have sought evidence of virus infection in healthy schoolchildren with islet cell antibodies (ICA), a prediabetic serological marker [10] [11] [12] [13] [14] . This study forms part of a wider study to assess additional makers of the prediabetic state, and their relationship to the presence of ICA [15] .
Subjects and methods

Study population
Between July 1988 and July 1989, 4208 students (age range 7-21 years; mean age 13.9 years) from 19 schools in Ulm/Alb-Donau County, FRG, were investigated. The aim of this study was to screen for markers which maybe associated with Type 1 diabetes, and to define the frequency of certain viral antibodies associated with the presence of ICA. The study was performed in accordance with the principles of the Declaration of Helsinki. Sera were stored at -20 ~ until they were used for further testing.
Of the 4208 pupils tested 44 (1.05%) were positive for ICA. These ICA-positive individuals were selected for antiviral antibody determination. The median age of ICA-positive subjects was 13.5 years (range 7-19 years). Six of the 44 (13.6 % ) were positive for complement-fixing ICA.
Control subjects
For each ICA-positive individual, an age and sex-matched classmate was selected, the serum sample being collected on the same day as that of the proband. ICA-positive sera were further tested for complement fixing-ICA using an indirect immunofluorescent method as described [16] . , FRG) . Only cytomegalovirus-IgG positive sera were tested for cytomegalovirus-IgA. Anti-Mumps antibodies of the IgG-and IgM type were tested by separate commercial ELISA's (Enzygnost-Parotitis, Behringwerke, Marburg, FRG). Anti-mumps IgM positive sera were tested by a second ELISA (mumps-IgM-ELA, Medac, Hamburg, FRG). Anti-mumps IgA antibodies were detected by indirect immunofluorescence test (Viramed, Martinsried, FRG). Only sera positive for anti-mumps IgG were tested for anti-mumps IgA.
Virus-specific antibody responses
The above-mentioned tests were all conducted and interpreted according to the manufacturer's instructions.
Statistical analysis
Fisher's exact test (two-tail) was applied to compare the antibody frequences of ICA-positive and ICA-negative control subjects.
Results
Most of the overall data on anti-viral antibodies in the 44 non-diabetic ICA-positive individuals and their ICAnegative matched control subjects are given in Table 1 . Of 35 ICA-positive individuals who answered a specific questionaire, 25 had been vaccinated for mumps and rubella virus 3 to 12 years prior to ICA testing.
The difference between coxsackie B1-5 specific IgM responses in the ICA-positive and ICA-negative control subjects was not statistically significant. No increase of anti-coxsackie B1-5 IgM responses could be found in the six individuals with CF-ICA; only two of the six were positive for anti-coxsackie Bl-5 IgM. The median age of the coxsackie B1-5 IgM-positive individuals was 12.1 years (range: 7-19 years) in the ICA-positive probands, and 12.0 years (range: 7-16 years) in the control subjects.
There were no increases in anti-mumps-IgM, antimumps-IgA, anti-cytomegalovirus-IgA, anti-cytomegalovirus-IgG or anti-rubella antibodies in ICA-positive as compared to control subjects.
Discussion
Islet cell antibodies indicating an autoimmune reaction to islet cells, are known to precede the onset of Type 1 diabetes by months or even years [10] [11] [12] [13] [14] . Assuming that viruses may play a role in the direct initiation of autoimmune insulitis, the association of recent virus infections with the appearance of ICA in the pre-diabetic period rather than at the onset of disease should be noted. Precise matching of patients and control subjects by area of residence is often difficult to achieve, particularly when the group studied consists of hospital in-patients [5] . The requirements for appropriate control subjects are ideally 837 met in our study where age-and sex-matched class-mates of the probands were used.
This study provided no evidence of an association between the presence of ICA and recent mumps, postnatally acquired rubella or cytomegalovirus infection. In previous studies no association between these virus infections and the onset of Type 1 diabetes was found [5] [6] [7] . Although mumps infection may result in transient ICA, islet cell surface antibodies and insulin-autoantibody responses [t9 -20] , and may occasionally cause Type i diabetes [21] , there is little evidence that these viruses are a significant cause of Type 1 diabetes.
The results of a low prevalence of IgM antibodies to the rubella and mumps viruses are not unexpected since IgM antibodies to these non-persistent viruses appear almost exclusively at primary infection. This is important in light of the fact that the prevalence of mumps or rubella immunity at age 13 was 76 % before the vaccination era, and 71% of our pupils who responded to a questionaire had been vaccinated previously. The low prevalence of recent infections in our cohort is also supported by the methodologically-unrelated measurement of IgA antibodies to mumps and cytomegalovirus.
Results of coxsackie B virus-specific IgM studies were less clear. Although the difference in prevalence between ICA positive and negative individuals was not statistically significant, a study of larger numbers would be required to exclude such an association. A number of serological studies have found a higher prevalence of coxsackie B virus-specific IgM responses in patients at Type 1 diabetes onset compared with control subjects [5, 8, 9, 22] while others have not [6] [7] . In one study, the prevalence of IgM among Type i diabetic patients showed considerable geographic and temporal variation, ranging from 0-76 % [9] . This probably reflects fluctuations in the prevalence of pancreotropic and diabetogenic strains of coxsackie B viruses. A clearer understanding of the role of coxsackie B and other enteroviruses in the pathogenesis of Type 1 diabetes is likely to require longitudinal study of ICA-positive subjects and other susceptible individuals, such as first-degree relatives of Type 1 diabetic patients. This would allow evidence of virus infections to be studied in relation to the appearance, rather than the presence of ICA and other pre-diabetic markers.
